Pediatric AML

Pediatric Oncology The Prognostic Significance of Incomplete Hematological Recovery in Pediatric AML Patients with Negative MRD Following Induction Therapy
Nessma Mahmoud Shahin • Mahmoud Hammad • Hanafy Hafez • Leslie E. Lehmann • Alaa Elhaddad
doi.org/10.69690/ODMJ-018-0425-3490
Pediatric Oncology Evaluation of the Clinical Outcomes Among the Pediatric Low-risk Acute Myeloid Leukemia Patients Who Received Four Versus Five Cycles of Chemotherapy: Single-center Study
Abeer ALAmer • Hala Omer • Eyad Saad • Omyma Ahmed • Saad Al Daama
doi.org/10.69690/ODMJ-018-0425-2830
Pediatric Oncology Response of Relapsed/ Refractory Pediatric AML to Clad-AraC
Rangasai Anirudh Neeli • Chetan Dhamne • Nirmalya R Moulik • Shyam Srinivasan • Akanksha Chichra • Gaurav Narula • Shripad Banavali
doi.org/10.69690/ODMJ-018-0425-1648